Pediatric Extrapolation in Type 2 Diabetes: Future Implications of a Workshop

Area of Science:

• Clinical Pharmacology
• Pediatric Endocrinology
• Drug Development

Background:

• Type 2 Diabetes (T2D) in youth presents unique challenges compared to adults.
• Extrapolation of adult data to pediatric populations requires careful consideration of disease manifestation and progression differences.

Purpose of the Study:

• To evaluate the team-based decision-making process for pediatric T2D development plans.
• To assess the feasibility and challenges of extrapolating adult clinical trial data to youth with T2D.

Main Methods:

• A mock-team workshop was conducted at the American Society for Clinical Pharmacology and Therapeutics (ASCPT) annual meeting.
• The workshop focused on a typical team-based approach to designing pediatric drug development strategies.
• Participants discussed the viability of using adult data for pediatric T2D drug development.

Main Results:

• The workshop highlighted key considerations and potential pitfalls in extrapolating adult T2D data to pediatric populations.
• Team discussions revealed the complexities in adapting adult development plans for youth.
• Specific challenges related to differing disease progression and manifestation in pediatric T2D were identified.

Conclusions:

• Pediatric drug development for T2D requires tailored approaches, not direct extrapolation from adult data.
• Team-based decision-making is crucial for navigating the complexities of pediatric T2D drug development.
• Further research is needed to establish robust methods for pediatric T2D drug development and extrapolation.